Clinical Trials
Study Title:
A Randomized Phase II Study of CHO(E)P vs CC 486 CHO(E)P vs Duvelisib CHO(E)P in Previously Untreated CD30 Negative Peripheral T Cell Lymphomas
For more information about the trial above please contact the study team:
Medical University of South Carolina Principal Investigator, Irl Greenwell, at greenwe@musc.edu, or please call +1 843-792-4759. Study Coordinator, Sarah Milligan, at millisar@musc.edu.
Trial opened at the following institutions: Medical University of South Carolina |